Literature DB >> 19022588

Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors.

Berenice Illades-Aguiar1, Enoc-Mariano Cortés-Malagón, Verónica Antonio-Véjar, Noelio Zamudio-López, Luz Del Carmen Alarcón-Romero, Gloria Fernández-Tilapa, Daniel Hernández-Sotelo, Marco-Antonio Terán-Porcayo, Eugenia Flores-Alfaro, Marco-Antonio Leyva-Vázquez.   

Abstract

BACKGROUND: This study was conducted to determine human papillomavirus (HPV) types in women with cervical cancer (CC) and normal cervical cytology in the Southern region of Mexico, and to know the contribution of HPV types and cofactors in cervical cancer etiology.
METHODS: A case-control study was performed in 133 women with CC and 256 controls. HPV detection was done by MY09/11 and GP5+/GP6+ PCR systems and typing by restriction fragment length polymorphism or DNA sequencing.
RESULTS: HPV was found in 100% of CC and 35.5% of controls. The genotype distribution in CC was: HPV 16 (66.8%), 18 (9%), 31 (7.5%), 45 (4.5%), 58 (3.7%), 69 (3%), 52 (1.6%), 6, 11, 33, 56, and 67 (0.8% each). Among controls, HPV 33 followed by HPV 16 were the most frequent. Cervical cancer was associated with HPV 16 (OR=573.5), HPV 18 (OR=804.4), and undetermined risk HPV (types 67 and 69) (OR=434.3). Age at first intercourse <16 years (OR=9.6) and > or =3 births (OR=16) were significant risk factors for CC.
CONCLUSIONS: HPV 16, by far, is the most frequent type in CC, HPV 16 and 18 are responsible for 75.8% of the CC cases and high-risk HPV for 94.7%, which is useful data to take into account in vaccination programs. HPV 33 is the most frequent type in controls and high-risk HPV are more common than low-risk HPV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022588     DOI: 10.1016/j.cdp.2008.09.001

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  14 in total

1.  Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions.

Authors:  Diana K Jiménez Tagle; Daniel Hernández Sotelo; Berenice Illades-Aguiar; Marco A Leyva-Vazquez; Eugenia Flores Alfaro; Yaneth Castro Coronel; Oscar Del Moral Hernández; Luz Del Carmen Alarcón Romero
Journal:  Int J Clin Exp Med       Date:  2014-01-15

2.  Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer.

Authors:  Laura Ortega-Cervantes; Adriana Aguilar-Lemarroy; Aurora Elizabeth Rojas-García; Briscia Socorro Barrón-Vivanco; Verónica Vallejo-Ruiz; David Cantú-De León; Yael Yvette Bernal Hernández; Armando Jáuregui-Martínez; Irma Martha Medina-Díaz
Journal:  Int J Health Sci (Qassim)       Date:  2016-07

3.  Prevalence of human papillomavirus in women from Mexico City.

Authors:  María Guadalupe López Rivera; Maria Olivia Medel Flores; José D'Artagnan Villalba Magdaleno; Virginia Sánchez Monroy
Journal:  Infect Dis Obstet Gynecol       Date:  2012-07-02

Review 4.  Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis.

Authors:  Agustín Ciapponi; Ariel Bardach; Demián Glujovsky; Luz Gibbons; María Alejandra Picconi
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

5.  HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.

Authors:  Michael Odida; Sven Sandin; Florence Mirembe; Bernhard Kleter; Wim Quint; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2011-06-25       Impact factor: 2.965

6.  Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies.

Authors:  Erik Bernard; Margarita Pons-Salort; Michel Favre; Isabelle Heard; Elisabeth Delarocque-Astagneau; Didier Guillemot; Anne C M Thiébaut
Journal:  BMC Infect Dis       Date:  2013-08-13       Impact factor: 3.090

7.  Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.

Authors:  Samantha E Rudolph; Attila Lorincz; Cosette M Wheeler; Patti Gravitt; Eduardo Lazcano-Ponce; Leticia Torres-Ibarra; Leith León-Maldonado; Paula Ramírez; Berenice Rivera; Rubí Hernández; Eduardo L Franco; Jack Cuzick; Pablo Méndez-Hernández; Jorge Salmerón
Journal:  BMC Infect Dis       Date:  2016-09-01       Impact factor: 3.090

8.  Prevalence and correlation of human papillomavirus genotypes with clinical factors in cervical samples from Mexican women.

Authors:  Fabiola Hernández-Rosas; Erika Orozco-Hernández; Liliana Maza-Sánchez; Pamela Citlalli Salgado-García; Enrique Navarro-Vidal; Mercedes Piedad de León-Bautista
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

9.  HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations.

Authors:  Francisco I Torres-Rojas; Miguel A Mendoza-Catalán; Luz Del C Alarcón-Romero; Isela Parra-Rojas; Sergio Paredes-Solís; Marco A Leyva-Vázquez; Jair E Cortes-Arciniega; Carlos J Bracamontes-Benítez; Berenice Illades-Aguiar
Journal:  PeerJ       Date:  2021-06-17       Impact factor: 2.984

10.  Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis.

Authors:  Raúl Peralta-Rodríguez; Pablo Romero-Morelos; Vanessa Villegas-Ruíz; Mónica Mendoza-Rodríguez; Keiko Taniguchi-Ponciano; Beatriz González-Yebra; Daniel Marrero-Rodríguez; Mauricio Salcedo
Journal:  Infect Agent Cancer       Date:  2012-12-03       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.